SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
Descripción del Articulo
Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PP...
Autores: | , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2022 |
Institución: | Colegio Médico del Perú |
Repositorio: | Acta Médica Peruana |
Lenguaje: | español |
OAI Identifier: | oai:ojs.pkp.sfu.ca:article/2033 |
Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/2033 |
Nivel de acceso: | acceso abierto |
Materia: | Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption |
id |
REVCMP_8ba40a028b43e6c47e36941aa7f2053c |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/2033 |
network_acronym_str |
REVCMP |
network_name_str |
Acta Médica Peruana |
repository_id_str |
. |
spelling |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospitalÍndice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de alturaMarmanillo Mendoza, GabrielaZuñiga Manrique, Rosario Elsa JesúsCornejo Del Valle, Oscar EduardoPortilla Canqui, Luis AlbertoCovid-19Hospital MortalityPrecctive Value of TestsSeverity of Illness IndexOxygen ConsumptionObjective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value.Objetivo: comparar el índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura. Materiales y métodos: estudio observacional, retrospectivo y transversal, donde se compararon la sensibilidad (S), especificidad (E), valor predictivo positivo (VPP) y valor predictivo negativo (VPN) de ambos índices. Resultados: La edad promedio de los pacientes con COVID-19 fue 62.2 ±12.8 años, el 73.7% fueron varones, las comorbilidades de mayor frecuencia fueron la diabetes mellitus (21.6%) y la hipertensión arterial (27.2%). Por otro lado el índice promedio SatO2/FiO2 fue 234.9 ±121.9 y el PaO2/FiO2 fue 169.7 ± 84 y el 30.5% de pacientes falleció. Se evidenció relación significativa entre los índices en mención y la mortalidad. Se obtuvo como puntos de corte 114.4 para SatO2/FiO2, con sensibilidad de 43.1%, especificidad de 91.2%, valor predictivo positivo de 68.3% y valor predictivo negativo de 78.5%, mientras que el punto de corte para PaO2/FiO2 fue 134.2, con sensibilidad de 63.1%, especificidad de 67.6%, valor predictivo positivo de 46.1% y valor predictivo negativo de 80.7%. Conclusión: Ambos índices son predictores de mortalidad, sin embargo el SatO2/FiO2 presentó mejores valores, con respecto a algunos de los criterios de sensibilidad, especificidad, valor predictivo positivo y valor predictivo negativo.Colegio Médico del Perú2022-02-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/203310.35663/amp.2021.384.2033ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - DecemberACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421Copyright (c) 2022 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/20332023-07-06T05:49:43Z |
dc.title.none.fl_str_mv |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital Índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura |
title |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
spellingShingle |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital Marmanillo Mendoza, Gabriela Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption |
title_short |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
title_full |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
title_fullStr |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
title_full_unstemmed |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
title_sort |
SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital |
dc.creator.none.fl_str_mv |
Marmanillo Mendoza, Gabriela Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto |
author |
Marmanillo Mendoza, Gabriela |
author_facet |
Marmanillo Mendoza, Gabriela Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto |
author_role |
author |
author2 |
Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption |
topic |
Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption |
description |
Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-02-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2033 10.35663/amp.2021.384.2033 |
url |
https://amp.cmp.org.pe/index.php/AMP/article/view/2033 |
identifier_str_mv |
10.35663/amp.2021.384.2033 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421 |
dc.rights.none.fl_str_mv |
Copyright (c) 2022 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 ACTA MEDICA PERUANA |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
publisher.none.fl_str_mv |
Colegio Médico del Perú |
dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - December ACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
instname_str |
Colegio Médico del Perú |
instacron_str |
CMP |
institution |
CMP |
reponame_str |
Acta Médica Peruana |
collection |
Acta Médica Peruana |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1816075110988120064 |
score |
13.949868 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).